deltatrials
Active Not Recruiting PHASE2/PHASE3 INTERVENTIONAL 3-arm NCT06814535

A Comparative Study on the Impact of Trigger Points Injection of Platelet Rich Plasma Versus Botulinum Toxin on the Relief of Jaw Muscles Myofascial Pain

A Comparative Study on the Impact of Trigger Points Injection of Platelet Rich Plasma Versus Botulinum Toxin a on the Relief of Jaw Muscles Myofascial Pain

Sponsor: Cairo University

Conditions Patients with Jaw Muscles Myofascial Pain
Interventions Botulinum Toxin A / Botulinum Toxin A Platelet rich plasma Saline -- placebo comparator
Updated 2 times since 2025 Last updated: Mar 8, 2025 Started: Jun 1, 2024 Primary completion: Mar 31, 2025 Completion: Mar 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06814535, this PHASE2/PHASE3 trial focuses on Patients with Jaw Muscles Myofascial Pain and remains ongoing. Sponsored by Cairo University, it has been updated 2 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Mar 2025 – ~Apr 2025 · 31 days · monthly snapshot~Apr 2025 – present · 16 months · monthly snapshotActive Not Recruiting

Change History

2 versions recorded

  1. Apr 2025 — Present [monthly]

    Active Not Recruiting PHASE2/PHASE3

  2. Mar 2025 — Apr 2025 [monthly]

    Active Not Recruiting PHASE2/PHASE3

    First recorded

Jun 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cairo University
Data source: Cairo University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations